ArticleCancer gene therapy2022

3JC48-3 (methyl 4'-methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1'-biphenyl]-3-carboxylate): a novel MYC/MAX dimerization inhibitor reduces prostate cancer growth.

Sanjeev Shukla et al.PubMed ↗Publisher ↗

No numbers read from the abstract.